Apadamtase alfa for treating congenital thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency [ID6192]
In development
Reference number: GID-TA11130
Expected publication date: TBC
Please note that following on from information received from the company, the timelines for this evaluation have been scheduled and the evaluation is now anticipated to begin in mid-April 2026.